Oncology & Cancer

Japan's DSP to buy US cancer start-up for $2.6 bn

Japanese drugs giant Dainippon Sumitomo Pharma will buy US biotechnology cancer specialist Boston Biomedical for a price that could hit $2.6 billion, the companies announced Thursday.

Vaccination

BioNTech mobile mRNA vaccine labs reach Rwanda

Six mobile vaccine production units by German pharma company BioNTech arrived in Rwanda on Monday, the first such shipments to Africa as the continent seeks to boost mRNA vaccine manufacturing.

Vaccination

Rwanda breaks ground on first mRNA vaccine plant

Rwanda and German pharma company BioNTech broke ground Thursday on Africa's first mRNA vaccine factory where cutting-edge treatments for diseases like COVID-19 will be made for millions across the continent.

Health

Meeting the health needs of Indigenous LGBTQ+ youth

Understanding the multiple identity groups of Aboriginal and Torres Strait Islander LGBTQ+ young people can assist in meeting their health care needs, according to the authors of a Perspective published online today by the ...

Oncology & Cancer

Merck KGaA suffers setback on cancer drug

German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.

page 2 from 2